JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Developed Asia Pacific-ex Japan ETF
BBAX
|
+$1.79B |
| 2 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.72B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.6B |
| 4 |
Deere & Co
DE
|
+$1.34B |
| 5 |
Amazon
AMZN
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares TIPS Bond ETF
TIP
|
+$1.61B |
| 2 |
Tesla
TSLA
|
+$1.54B |
| 3 |
TSMC
TSM
|
+$1.51B |
| 4 |
Salesforce
CRM
|
+$1.32B |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 25.65% |
| 2 | Technology | 15.75% |
| 3 | Financials | 11.13% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Healthcare | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4376
Gyre Therapeutics
GYRE
$742M
| $640K | ﹤0.01% |
16,929
+5,757
| +52% | +$263K |
2020 Q2
3 quarters
|
|
|
AGS
4377
DELISTED
PlayAGS
AGS
| $637K | ﹤0.01% |
78,842
+15,698
| +25% | +$112K |
2018 Q1
12 quarters
|
|
4378
Madrigal Pharmaceuticals
MDGL
$11.5B
| $637K | ﹤0.01% |
5,441
+1,469
| +37% | +$171K |
2017 Q3
14 quarters
|
|
4379
Chemung Financial Corp
CHMG
$389M
| $635K | ﹤0.01% |
15,185
+65
| +0.4% | +$2.43K |
2016 Q4
17 quarters
|
|
|
APTX
4380
DELISTED
Aptinyx Inc. Common Stock
APTX
| $635K | ﹤0.01% |
211,639
-109,498
| -34% | -$393K |
2018 Q2
11 quarters
|
|
|
NAACU
4381
DELISTED
North Atlantic Acquisition Corporation Unit
NAACU
| $631K | ﹤0.01% |
+63,489
| New | +$651K |
2021 Q1
0 quarters
|
|
4382
Vanguard Russell 2000 Value ETF
VTWV
$1.31B
| $630K | ﹤0.01% |
4,509
-43,603
| -91% | -$5.77M |
2020 Q2
3 quarters
|
|
4383
V2X
VVX
$2.22B
| $630K | ﹤0.01% |
11,792
-76,147
| -87% | -$4.18M |
2015 Q3
22 quarters
|
|
|
ALR
4384
DELISTED
AlerisLife Inc
ALR
| $628K | ﹤0.01% |
102,657
+39,502
| +63% | +$285K |
2020 Q1
4 quarters
|
|
4385
CALL
CSX Corp
CSX
$86.2B
| $627K | ﹤0.01% |
+19,500
| New | +$595K |
2021 Q1
0 quarters
|
|
|
TAST
4386
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $626K | ﹤0.01% |
104,661
-12,602
| -11% | -$82.2K |
2017 Q4
13 quarters
|
|
4387
Vanguard ESG US Stock ETF
ESGV
$13.5B
| $625K | ﹤0.01% |
8,480
+6,555
| +341% | +$475K |
2020 Q3
2 quarters
|
|
4388
TechTarget
TTGT
$268M
| $624K | ﹤0.01% |
8,983
-17,921
| -67% | -$1.39M |
2016 Q2
19 quarters
|
|
4389
Universal Logistics Holdings
ULH
$467M
| $624K | ﹤0.01% |
23,702
-11,194
| -32% | -$269K |
2013 Q2
31 quarters
|
|
|
GSS
4390
DELISTED
Golden Star Resources Ltd.
GSS
| $624K | ﹤0.01% |
211,437
-6,708
| -3% | -$23.4K |
2015 Q4
21 quarters
|
|
4391
Boston Omaha
BOC
$391M
| $623K | ﹤0.01% |
21,054
+9,113
| +76% | +$330K |
2018 Q2
11 quarters
|
|
|
CBPO
4392
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $622K | ﹤0.01% |
5,257
-30
| -0.6% | -$3.55K |
2017 Q3
14 quarters
|
|
|
ESTE
4393
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $622K | ﹤0.01% |
86,994
+28,505
| +49% | +$193K |
2017 Q4
13 quarters
|
|
4394
Immersion
IMMR
$243M
| $621K | ﹤0.01% |
64,801
+15,148
| +31% | +$180K |
2017 Q4
13 quarters
|
|
4395
Applied Optoelectronics
AAOI
$9.11B
| $620K | ﹤0.01% |
74,108
-136
| -0.2% | -$1.36K |
2016 Q3
18 quarters
|
|
|
DVAX
4396
DELISTED
Dynavax Technologies
DVAX
| $618K | ﹤0.01% |
62,864
+15,036
| +31% | +$124K |
2016 Q3
18 quarters
|
|
|
ADAG
4397
Adagene
ADAG
$197M
| $617K | ﹤0.01% |
+34,360
| New | +$783K |
2021 Q1
0 quarters
|
|
4398
Corbus Pharmaceuticals
CRBP
$123M
| $617K | ﹤0.01% |
10,433
+1,797
| +21% | +$118K |
2017 Q4
13 quarters
|
|
4399
BeyondSpring
BYSI
$33.5M
| $616K | ﹤0.01% |
55,654
+18,323
| +49% | +$237K |
2019 Q2
7 quarters
|
|
4400
Oil-Dri
ODC
$1.32B
| $616K | ﹤0.01% |
35,722
+1,446
| +4% | +$25.6K |
2017 Q4
13 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2021 Portfolio in Review
As of Q1 2021, JP Morgan Chase held 6,599 positions worth $749B, up 10% from $681B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
JP Morgan Chase deployed $36.2B of net new capital in Q1 2021, opening 866 new positions and adding to 2,869 existing holdings. Its largest new stake was Ferguson: 4,925,283 shares worth $592M.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares TIPS Bond ETF, an estimated $1.61B trimmed.
- JP Morgan Chase's largest Q1 2021 buy was Ferguson: 4,925,283 shares worth $592M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Developed Asia Pacific-ex Japan ETF in Q1 2021, an estimated $1.79B increase.
- JP Morgan Chase's biggest Q1 2021 reduction was iShares TIPS Bond ETF, cutting an estimated $1.61B.
- JP Morgan Chase fully exited TC Pipelines LP in Q1 2021, selling an estimated $65.2M.
- JP Morgan Chase's ten largest holdings make up 15% of its $749B portfolio in Q1 2021.
- JP Morgan Chase opened 866 new positions and closed 461 in Q1 2021.
- JP Morgan Chase's portfolio value rose 10% quarter-over-quarter to $749B.
Based on JP Morgan Chase's 13F filing for Q1 2021, filed 12 May 2021.